Lakesha sells TKMR 18.6: Tekmira Provides Corporate Update And Announces Second Quarter 2014 Results
VANCOUVER, British Columbia, Aug. 13, 2014 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, today announced its financial and operating results for the second ... ...
26 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home